• C8-HSL and Lung Cancer Progression via PI3K/AKT/ERK

  2026-09-18

  A 2026 FASEB Journal study identifies the bacterial quorum-sensing molecule C8-HSL as a promoter of H460 lung cancer cell proliferation, migration, and invasion through PI3K/AKT/ERK pathway activation. The work provides an early mechanistic bridge between microbial signaling and tumor-cell behavior while highlighting the need for validation in additional models and patient-relevant systems.

• Molidustat (BAY85-3934) Workflow Guide

  2026-09-18

  Molidustat (BAY85-3934) provides a controllable way to study HIF-PH inhibition, endogenous erythropoietin stimulation, and oxygen-sensing biology. This workflow connects renal anemia research with a mechanistic cardiomyocyte study while separating validated findings from testable experimental hypotheses.

• TMRE mitochondrial membrane potential assay kit Guide

  2026-09-17

  Translate mitochondrial depolarization into actionable data for apoptosis, sodium-overload necrosis, and mitochondrial function analysis. This guide combines the TMRE mitochondrial membrane potential assay kit with a controlled workflow, CCCP validation, and mechanistic interpretation based on recent NECSO research.

• Cy3 Goat Anti-Human IgG (H+L) Antibody Guide

  2026-09-17

  Turn human IgG binding into a bright, spatially resolved Cy3 readout across immunofluorescence, tissue imaging, flow cytometry, and ELISA. This workflow-focused guide explains how to pair the reagent with orthopoxvirus antibody studies while avoiding species mismatches, autofluorescence, and overinterpretation of binding data.

• Amitriptyline HCl: Practical Assay Guide

  2026-09-16

  This guide helps researchers use Amitriptyline HCl (SKU B2231) in controlled neurotransmitter receptor modulation and neuropharmacology workflows. It covers solution preparation, assay controls, storage, and interpretation boundaries; it should not be used as evidence for clinical efficacy or unvalidated disease-model outcomes.

• DAPT (GSI-IX) for Notch Signaling Assays

  2026-09-16

  DAPT (GSI-IX) provides a controllable way to inhibit γ-secretase while separating Notch-dependent phenotypes from broader cellular effects. This guide translates angiogenesis findings from a critical limb ischemia study into practical cell-based workflows, dose planning, validation strategies, and troubleshooting steps.

• β-Pseudouridine in RNA Vaccine Assay Design

  2026-09-15

  β-Pseudouridine connects RNA modification biology with rigorous vaccine-platform comparisons. This article explains how to distinguish nucleoside chemistry from self-amplifying RNA effects and design assays that measure structure, translation, and translational fidelity without overclaiming causality.

• PPT: A Decision Framework for ERα–LUAD Studies

  2026-09-15

  PPT (Propyl Pyrazole Triol) enables selective interrogation of ERα signaling in female lung adenocarcinoma. This guide translates biomarker-network evidence into a practical framework for separating receptor competence, transcriptional response, and disease-associated mechanism.

• Multimodal Radiopathomics Predicts Gastric Cancer Response

  2026-09-14

  This reference study integrates baseline computed tomography and digital H&E pathology with interpretable machine learning to predict response to immunotherapy-based combination therapy in gastric cancer. Its radiopathomics signature showed strong discrimination across internal and external cohorts and linked imaging-pathology patterns with immune regulation and memory B-cell infiltration, providing a framework for more biologically informed treatment stratification.

• Artesunate B3662: Reliable Cell Assays

  2026-09-14

  A scenario-driven guide to using Artesunate (SKU B3662) in viability, proliferation, and cytotoxicity workflows. It addresses solvent handling, dose interpretation, ferroptosis-focused experiments, and vendor selection using product specifications and published guidance on distinguishing growth inhibition from true cell killing.

• Puerarin, NO Signaling, and Dental Follicle Osteogenesis

  2026-09-13

  The reference study identifies nitric oxide signaling as a mechanistic component of puerarin-induced osteogenic differentiation in rat dental follicle cells. By combining osteogenic readouts with L-NMMA-mediated pathway inhibition, it connects NO, cGMP, soluble guanylate cyclase, and PKG-1 signaling to periodontal regeneration research while leaving isoform-specific and translational questions unresolved.

• Sulfisomidine Workflows for Enzyme and Microbial Studies

  2026-09-12

  Sulfisomidine, also known as sulfamethin, supports both hPON1 enzyme kinetics and bacterial folate-pathway experiments. Its environmental degradation profile adds a practical matrix-aware dimension for researchers tracking transformation products and evolving toxicity.

• NF 340: Reframing P2Y11 in Cancer Invasion

  2026-09-11

  NF 340 provides a receptor-level way to interrogate the QPRT–purinergic signaling axis in breast cancer invasion. This thought-leadership guide connects the anchor study to experimental design, immunology research, inflammation pathway modulation, and translational decision-making without overstating therapeutic evidence.

• TSA, ERK/FoxO3a, and Autophagic Flux in Pancreatitis

  2026-09-11

  The reference study identifies impaired ERK/FoxO3a regulation as a mechanistic link between trichostatin A treatment and restoration of autophagic flux in acute pancreatitis. By combining network pharmacology, AR42J-cell experiments, pharmacological pathway perturbation, and rat validation, it provides a framework for testing autophagy-centered interventions while highlighting the limits of inferring pathway causality from inhibitor and activator studies.

• Isoprinosine Workflows for Herpesvirus Assays

  2026-09-10

  Isoprinosine, or inosine pranobex, provides a practical host-response perturbation for viral replication, immune signaling, and herpesvirus nuclear-egress experiments. This workflow pairs dose-ranging and orthogonal readouts with the CLCC1 membrane-fusion discovery, helping researchers distinguish immunomodulation from direct effects on viral trafficking.

8598 records 1/574 page Next 12345 下5页 Last page